2017 The new Capital, page-422

From AFR:

Elsewhere in the health sector, shares in the rejuvenated Capitol Health are on a tear thanks to a timely equity raising, chunky asset sale, plans for restated dividends and even a share buyback.

Fund manager attention, though, has turned to Capitol's 20 per cent stake in US deep learning play Enlitic.
Street Talk can reveal that Enlitic management has been doing the rounds with local fundies with the help of Shaw and Partners in recent weeks, sparking thoughts of a potential ASX listing of its own.

Enlitic last raised funds at a $50 million valuation about 12-months ago, and there is a view it could be worth $100 million or more should it be spun off in the next six months. That would represent a tidy profit for Capitol.
Should it happen as the bulls reckon, then Capitol's run has only just begun.


Read more: http://www.copyright link/street-ta...o-cash-and-burn-20170724-gxhyzw#ixzz4ntBGGlJv